Form 4 Tracker
Robert J Alpern

Director · 2 filings · Latest: Mar 31, 2026

ABBOTT LABORATORIES
AbbVie Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ABBV
ROBERT J ALPERNMay 26, 2026
Proposed Sale
$214.0013,000$2.8M
ABT
Robert J. AlpernMay 15, 2026
Proposed Sale
$85.257,587$646.8K
ABT
Robert J. AlpernApr 27, 2026
Proposed Sale
$92.5529,211$2.7M